CNBC · 1 min read

The startup using AI to help rare disease families develop custom treatments

The startup using AI to help rare disease families develop custom treatments

Nome uses AI and drug-development expertise to help rare disease families turn genetic diagnoses into potential paths toward treatment.

This is a summary aggregated from CNBC. Read the complete article on the original site:

Read full article at CNBC

More Startup & VC News